|
Re: Tweet from Dr. KKZ (our guy) on SARS - CoV - 2 relationship to CKD
|
2
|
Resverlogix Corp.
|
Apr 10, 2020 07:07PM
|
|
Re: Little confused, any insight would be great
|
2
|
Resverlogix Corp.
|
Mar 11, 2024 03:20PM
|
|
Management Information Circular
|
2
|
Resverlogix Corp.
|
Jul 10, 2024 07:40PM
|
|
Re: Closing on the Saudi deal..
|
2
|
Resverlogix Corp.
|
Jan 15, 2021 08:22PM
|
|
Re: Fun and games?
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 12:05PM
|
|
Re: Why worry about the Third Eye loan?
|
2
|
Resverlogix Corp.
|
Aug 27, 2019 03:52PM
|
|
Re: CASH
|
2
|
Resverlogix Corp.
|
Oct 05, 2019 03:32PM
|
|
Re: NASDAQ IPO questions
|
2
|
Resverlogix Corp.
|
Sep 09, 2018 06:07AM
|
|
Re: A Special Meeting of Shareholders?
|
2
|
Resverlogix Corp.
|
Jun 07, 2024 10:30AM
|
|
Exempt Distribution - 2022-04-14
|
2
|
Resverlogix Corp.
|
Apr 17, 2022 07:34PM
|
|
Re: Reply from IR...no surprise, there's nothing there:
|
2
|
Resverlogix Corp.
|
Oct 29, 2019 02:20PM
|
|
Re: Carotid stenosis study
|
2
|
Resverlogix Corp.
|
Feb 26, 2020 05:32PM
|
|
Re: ACE2 again identified as the key protein to regulate
|
2
|
Resverlogix Corp.
|
Nov 23, 2020 08:00AM
|
|
Re: 3rd party rumour ..
|
2
|
Resverlogix Corp.
|
Nov 26, 2020 07:32AM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
2
|
Resverlogix Corp.
|
Jan 13, 2021 06:59PM
|
|
Re: Primary outcome HR= .82 (18% RRR) P=0.11
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 12:05PM
|
|
Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 05, 2023 06:22AM
|
|
Re: When are next earning reports due?
|
2
|
Resverlogix Corp.
|
Jan 22, 2019 01:40PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 21, 2024 11:36AM
|
|
Re: Fun and games?
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 12:12PM
|
